ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailMenu BurgerPositive ArrowIcon PrintIcon SearchSite TitleTitle ChevronIcon Twitter
Retail Trade

cocokara fine, Inc.

Business Summary

cocokara fine, Inc. engages in the planning and management of its group companies that are involved in drugstore chain operations. It operates through the following segments: Drug Store and Pharmacy Business, Nursing Care Business, and Others. The Drug Store and Pharmacy Business segment deals with the retail distribution of pharmaceutical products, cosmetics, and household items. The Nursing Care Business segment operates nursing care facilities and offers home-care services. The Others segment covers wholesale, e-commerce and international businesses. The company was founded on April 1, 2008 and is headquartered in Yokohama, Japan.

Financial Highlights

Mar 2019 JPYUSD
Revenue400,559M3,612.06M
Gross Profit104,914M946.06M
Operating income12,905M116.37M
Income before tax13,795M124.39M
Net income9,158M82.58M
EBITDA16,870M152.12M
Diluted EPS381.243.43
Dividends Per Share760.68
Total Assets172,727M1,560.52M
Total liabilities77,644M701.48M
Total equity95,081M859.02M
Operating cash flow9,388M84.65M
Currency in JPYCurrency in USD

Historical Data

 Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Revenue 349,164M 373,275M 377,203M 390,963M 400,559M
Gross Profit 85,323M 92,774M 93,564M 101,205M 104,914M
Operating income 4,367M 11,119M 10,140M 13,665M 12,905M
Income before tax 4,252M 11,705M 11,339M 14,638M 13,795M
Net income 1,658M 6,927M 7,037M 9,067M 9,158M
EBITDA 8,488M 15,022M 14,162M 17,641M 16,870M
Diluted EPS 65.29 279.32 286.79 376.38 381.24
Dividends Per Share 60 70 70 73 76
Total Assets 135,610M 142,404M 146,963M 158,177M 172,727M
Total liabilities 60,375M 64,449M 63,723M 70,365M 77,644M
Total equity 75,235M 77,955M 83,237M 87,810M 95,081M
Operating cash flow 7,165M 17,809M 9,381M 17,117M 9,388M
 Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Revenue 3,178.36M 3,108.44M 3,483.34M 3,527.51M 3,612.06M
Gross Profit 776.67M 772.57M 864.03M 913.13M 946.06M
Operating income 39.75M 92.59M 93.63M 123.29M 116.37M
Income before tax 38.70M 97.47M 104.71M 132.07M 124.39M
Net income 15.09M 57.68M 64.98M 81.80M 82.58M
EBITDA 77.26M 125.09M 130.78M 159.16M 152.12M
Diluted EPS 0.59 2.32 2.64 3.39 3.43
Dividends Per Share 0.54 0.58 0.64 0.65 0.68
Total Assets 1,130.79M 1,266.99M 1,318.88M 1,487.32M 1,560.52M
Total liabilities 503.43M 573.41M 571.86M 661.63M 701.48M
Total equity 627.35M 693.58M 746.98M 825.66M 859.02M
Operating cash flow 65.22M 148.30M 86.63M 154.44M 84.65M

Valuation Measures

Mar 2019
PER11.52
ROA5.53%
ROE10.01%
Operating margin3.22%
Profit margin2.28%

Key executives

  • President & Representative Director: Atsushi Tsukamoto
  • Manager-Information Technology Development: Yasuyuki Oike
  • Director, VP, GM-Administration & Manager-Strategy: Tsuyoshi Yamamoto
  • Executive Officer & Team Manager-IT: Hiroyasu Satake
  • Executive Officer & Team Manager-Labor: Yuichi Kanemoto

Shareholders

  • Seishin Kagaku Kai (6.6%)
  • cocokara fine, Inc. (5.4%)
  • Pictet Asset Management Ltd. (3.9%)
  • Cocokara Fine Holdings Employee Stock Ownership Plan (3.5%)
  • SEGAMI FAMILY (3.2%)
  • Daiichi Sankyo Co., Ltd. (2.3%)
  • SAITO MAYUMI (2.3%)
  • Baillie Gifford & Co. (2.0%)
  • Nomura Asset Management Co., Ltd. (1.9%)
  • The Vanguard Group, Inc. (1.9%)

Contact Details

Related Companies

  • Flight YK
  • Koishikawa Pharmacy KK
  • K S YK
  • Cocokara Fine Employee Incentive Plan
  • Senior Cosmos Co., Ltd.
  • Toho Chozai YK
  • cocokarafine soleil Co. Ltd.
  • Yamamoto Service KK
  • Shanghai Cocokara Fine, Inc.
  • Cocokara Fine Next Co., Ltd.
  • cocokarafine associe, Inc.
  • cocokara fine OEC, Inc.
  • Cocokara fine Healthcare, Inc.
  • I System KK (Yamaguchi)
  • Kojido Corp.
  • Kusuri No Ebina YK
  • Finecare, Inc.
  • Kodama Co., Ltd. (Niigata)
  • Reha Works YK
  • Medical Index YK
  • Aianju KK
  • SO Pharmaceutical Corp.
  • Cocokara Fine Holdings Employee Stock Ownership Plan
  • Koshi Yakkyoku YK
  • Iwasaki Kokendo KK
  • Suzuran Pharmacy KK
  • Takara Care Co. Ltd.
  • Segami Medics Co. Ltd.
  • Seijo Corp.

Competitors

  • Create SD Holdings Co., Ltd.
  • Welcia Holdings Co., Ltd.
  • Pharmarise Holdings Corp.
  • SOGO MEDICAL HOLDINGS CO.,LTD.
  • COSMOS Pharmaceutical Corporation
  • KUSURI NO AOKI HOLDINGS CO.,LTD.
  • Qol Holdings Co., Ltd.
  • Sugi Holdings Co., Ltd.
  • Sundrug Co., Ltd.
  • TSURUHA Holdings, Inc.
  • Nihon Chouzai Co., Ltd.
  • Ain Holdings Inc.
  • Matsumotokiyoshi Holdings Co., Ltd.
  • Medical System Network Co., Ltd.
Last Updated on 11 Oct, 2019

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Get Unlimited access

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends October 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media